High-throughput, high-content imaging (HCI) assays for the key cellular events of neurodevelopment have been proposed to rapidly evaluate chemicals for developmental neurotoxicity. Thus, in vitro assays using neural cell cultures are being developed for key neurodevelopmental events, including proliferation, neural differentiation, migration, synaptogenesis, and neurite outgrowth. The advent of human induced pluripotent stem cell (iPSC)-derived neurons provides a novel model system. Human iPSC-derived neurons demonstrate the morphology and physiology of their in situ counterparts and have been commercialized and made available in large numbers, facilitating their use in chemical testing. The present study evaluated the neuronal characteristics of commercially available, cryopreserved human iPSC-derived neurons (iCell® neurons). Immunocytochemistry revealed a relatively pure population of neurons that extended both putative axons and dendrites. The cells developed neurites rapidly and consistently as quantified using automated HCI. Exposure to a training set of eight chemicals previously demonstrated to affect neurite outgrowth in rodent and/or human neurons resulted in concentration-dependent decreases in neurite outgrowth in human iCell neurons, although the response to chemicals was different from the response observed in rat cortical neurons. Lead and U0126 had no effect in rat cortical neurons but decreased neurite outgrowth in human neurons. In contrast, etoposide decreased both neurite outgrowth and viability in rat primary cortical cultures, but was much less potent in human iPSC-derived neurons. Together, these data demonstrate that commercially available human iPSC-derived neurons are amenable for use in medium- to high-throughput assays of neurite outgrowth using HCI. Though limited, the data indicate that human and rodent neurons can respond differently to chemical insult, and suggest that in vitro toxicity testing should include the use of human-derived cells.
Get full access to this article
View all access options for this article.
References
1.
U.S. Environmental Protection Agency. U.S. Environmental Protection Agency Health Effects Test Guidelines. OPPTS 870.6300. Developmental Neurotoxicity Study. EPA Document 712-C-98-239. Washington, DC; 1998.
LeinP, LockeP, GoldbergA. Meeting report: Alternatives for developmental neurotoxicity testing. Env Health Perspect, 2007:115; 764–768.
4.
De GrootMW, WesterinkRH, DingemansMM. Don't judge a neuron only by its cover: Neuronal function in in vitro developmental neurotoxicity testing. Toxicol Sci, 2013:132; 1–7.
5.
Bal-PriceAK, CoeckeS, CostaL, et al.Advancing the science of developmental neurotoxicity (DNT): Testing for better safety evaluation. ALTEX, 2012:29; 202–215.
6.
CoeckeS, GoldbergAM, AllenS, et al.Workgroup report: Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Env Health Perspect, 2007:115; 924–931.
7.
RadioNM, BreierJM, ReifDM, et al.Use of neural models of proliferation and neurite outgrowth to screen environmental chemicals in the ToxCast phase I library. Appl In Vitro Toxicol, 2015:1; 131–139.
8.
RadioNM, MundyWR. Developmental neurotoxicity testing in vitro: Models for assessing chemical effects on neurite outgrowth. Neurotoxicology, 2008:29; 361–376.
9.
NRC. Toxicity Testing in the 21st century: A Vision and a Strategy. Washington, DC: National Academic Press; 2007.
10.
ContiL, CattaneoE. Neural stem cell systems: Physiological players or in vitro entities?. Nature Rev, 2010:11; 176–187.
11.
MoorsM, RockelTD, AbelJ, et al.Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Env Health Perspect, 2009:117; 1131–1138.
12.
SenutMC, SenA, CingolaniP, et al.Lead exposure disrupts global DNA methylation in human embryonic stem cells and alters their neuronal differentiation. Toxicol Sci, 2014:139; 142–161.
13.
ZimmerB, PalloccaG, DreserN, et al.Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery. Arch Toxicol, 2014:88; 1109–1126.
14.
HarrillJA, FreudenrichTM, MachacekDW, et al.Quantitative assessment of neurite outgrowth in human embryonic stem cell-derived hN2 cells using automated high-content image analysis. Neurotoxicology, 2010:31; 277–90.
15.
GassmannK, AbelJ, BotheH, et al.Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs. Env Health Perspect, 2010:118; 1571–1577.
16.
McNeishJ, RoachM, HamborJ, et al.High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors. J Biol Chem, 2010:285; 17209–17217.
17.
HarrillJA, FreudenrichTM, RobinetteBL, et al.Comparative sensitivity of human and rat neural cultures to chemical-induced inhibition of neurite outgrowth. Toxicol Appl Pharmacol, 2011:256; 268–280.
18.
DragunowM. High-content analysis in neuroscience. Nat Rev Neurosci, 2008:9; 779–788.
19.
TakahashiK, TanabeK, OhnukiM, et al.Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007:131; 861–872.
20.
ParkIH, ZhaoR, WestJA, et al.Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 2008:451; 141–146.
21.
HuBY, WeickJP, YuJ, et al.Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA, 2010:107; 4335–4340.
22.
AignerS, HeckelT, ZhangJD, et al.Human pluripotent stem cell models of autism spectrum disorder: Emerging frontiers, opportunities, and challenges towards neuronal networks in a dish. Psychopharmacology (Berl), 2014:231; 1089–1104.
23.
XuX, LeiY, LuoJ, et al.Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events. Stem Cell Res, 2013:10; 213–227.
24.
SirenkoO, HesleyJ, RusynI, et al.High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures. Assay Drug Dev Technol, 2014:12; 536–547.
25.
CroftonKM, MundyWR, LeinPJ, et al.Developmental neurotoxicity testing: Recommendations for developing alternative methods for the screening and prioritization of chemicals. ALTEX, 2011:28; 9–15.
26.
HarrillJA, RobinetteBL, FreudenrichTM, et al.Media formulation influences chemical effects on neuronal growth and morphology. In Vitro Cell Dev Biol Anim, 2015:51; 612–629.
27.
ShiSH, JanLY, JanYN. Hippocampal neuronal polarity specified by spatially localized Par3/mPar6 and PI 3-kinase activity. Cell, 2003:112; 63–75.
28.
AudesirkT, AudesirkG, FergusonC, ShugartsD. Effects of inorganic lead on the differentiation and growth of cultured hippocampal and neuroblastoma cells. Neurotoxicology, 1991:12; 529–538.
29.
TakahashiM, YasutakeK, TomizawaK. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. J Neurochem, 1999:73; 2073–2083.
30.
KrugAK, BalmerNV, MattF, et al.Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch Toxicol, 2013:87; 2215–2231.
31.
BlakelyBD, ByeCR, FernandoCV, HorneMK, et al.Wnt5a regulates midbrain dopaminergic axon growth and guidance. PLoS One, 2011:6; e18373.
32.
MandellJW, BankerGA. Selective blockade of axonogenesis in cultured hippocampal neurons by the tyrosine phosphatase inhibitor orthovanadate. J Neurobiol, 1998:35; 17–28.
33.
RadioNM, BreierJM, ShaferTJ, MundyWR. Assessment of chemical effects on neurite outgrowth in PC12 cells sing high content screening. Toxicol Sci, 2008:105; 106–118.
34.
DageJL, ColvinEM, FouilletA, et al.Pharmacological characterization of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons. Psychopharmacology (Berl), 2014:231; 1105–1124.
35.
MeneghelloG, VerheyenA, Van IngenM, et al.Evaluation of established human iPSC-derived neurons to model neurodegenerative diseases. Neuroscience, 2015:301; 204–212.
36.
RadioNM, FreudenrichTM, RobinetteBL, et al.Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis. Neurotoxicol Teratol, 2010:32; 25–35.
37.
NakanishiK, AonoS, HiranoK, et al.Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J Biol Chem, 2006:281; 24970–24978.
38.
SperanzaL, ChamberyA, Di DomenicoM, et al.The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways. Neuropharmacology, 2013:67; 155–167.
39.
ObertoA, MarksN, EvansHL, et al.Lead (Pb +2) promotes apoptosis in newborn rat cerebellar neurons: Pathological implications. J Pharmacol Exp Ther, 1996:279; 435–442.
40.
BragaMF, PereiraEF, MikeA, et al.Pb2+ via protein kinase C inhibits nicotinic cholinergic modulation of synaptic transmission in the hippocampus. J Pharmacol Exp Ther, 2004:311; 700–710.
41.
NealAP, GuilarteTR. Molecular neurobiology of lead (Pb(2+)): Effects on synaptic function. Mol Neurobiol, 2010:42; 151–160.
42.
van MaanenJM, RetèlJ, de VriesJ, et al.Mechanism of action of antitumor drug etoposide: A review. J Natl Cancer Inst, 1988:80; 1526–1533.
43.
KimJE, HanBS, ChoiWS, et al.Temporospatial sequence of cellular events associated with etoposide-induced neuronal cell death: Role of antiapoptotic protein Bcl-X(L). J Neurosci Res, 2001:66; 1074–1082.
44.
LothariusJ, FalsigJ, van BeekJ, et al.Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci, 2005:25; 6329–6342.
45.
DruweI, FreudenrichTM, WallaceK, et al.Sensitivity of neuroprogenitor cells to chemical-induced apoptosis using a multiplexed assay suitable for high-throughput screening. Toxicology, 2015:333; 14–24.
